Blue Shield of California is collecting D1 Premium Contribution data as part of the Consolidated Appropriations Act, Section 204 (2021)–Prescription Drug Cost Reporting regulation, on behalf of employer groups.
Groups or their brokers with access to an Employer Connection account are encouraged to complete the survey by logging in to Employer Connection.
Groups or their brokers without access to an Employer Connection account can submit required information via the Prescription Drug & Healthcare Spending Survey using their group ID and following web key: #25yr24
The deadline to submit information is April 19, 2025.
Groups that miss the deadline will not be included in Blue Shield’s filing and may be subject to non-compliance if they do not report the required data directly to the CMS on their own.
As a reminder, Blue Shield will submit D2 for all groups and D3-D8 for groups with prescription drug benefits under a Blue Shield health benefit plan. Please note that data submitted is for the 2024 calendar year.
Here are a few reminders to prepare for submission:
- Only one individual (group administrator, broker, or other such delegate) may submit responses for a single group ID. Please coordinate a single submission.
- Submitters will receive an email confirmation displaying a record of responses submitted and a link to edit responses.
- Only the submitter will have access to edit responses until the deadline.
Blue Shield is committed to supporting their groups in complying with health coverage related regulatory requirements.* Please support your groups by reminding them to submit necessary information before the deadline and helping submit information, as needed. Blue Shield will send a follow up email to groups that have not yet completed the survey, reminding them to complete the survey before the deadline.
Please view the Prescription Healthcare Spending Survey FAQs for more information.
*Blue Shield does not provide legal advice. Please consult your legal advisor to confirm your group’s compliance with CAA Section 204 (2021).